EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Therapeutic approach in the critically ill patient with suspected multidrug resistance

María Cruz Soriano-Cuesta iD, Marina López-Olivencia iD, Francisco Javier Candel iD, Susana García-Plaza iD

Revista Española de Quimioterapia · 24.10.2025 · 38 (S1) · 63-69

DOI: 10.37201/req/s01.10.2025 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Revista Española de Quimioterapia, online erschienen am 24.10.2025. Verfasst von María Cruz Soriano-Cuesta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Intensive Care Medicine Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. cruzsoriano@gmail.com. Hauptthemen laut MEDLINE: Critical Illness, Drug Resistance, Multiple, Bacterial, Anti-Bacterial Agents, Bacterial Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The treatment of infections caused by multidrug-resistant microorganisms (MDROs) in critically ill patients remains a major clinical challenge due to the high mortality associated with therapeutic failure. Delays in administering effective antibiotics is a determining factor, especially in patients with sepsis. The presence of MDROs is one of the main causes of failure of empirical treatment. Identifying patients at risk of MDRO infection is essential, although complex. Factors such as prior use of antibiotics disrupt the intestinal microbiome balance and promote colonization by MDROs. Immunosuppression, disruption of physical barrier, systemic or organ-specific frailty, and the length of hospital stay increase the risk of colonization and infection by MDROs. In patients with sepsis and a high risk of MDRO infection, empirical therapy should be broad-spectrum and administered early. Traditionally, combination therapy has been recommended, preferably including a classical β-lactam together with aminoglycosides or colistin—drugs that may be suboptimal in certain infection sites and are associated with significant toxicity risks. The new broad-spectrum β-lactams, already validated as first-line targeted treatment, are emerging as a promising empirical option in selected patients. Their early use, guided by colonization status, can optimize initial coverage in terms of spectrum and pharmacokinetic/pharmacodynamic, and reduces delays in the initiation of effective treatment. This strategy should be integrated into antimicrobial stewardship programs and be followed by de-escalation once microbiological results are available.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Critical IllnessDrug Resistance, Multiple, BacterialAnti-Bacterial AgentsBacterial InfectionsHumansSepsisDrug Therapy, Combination

Stichwörter der Autor:innen

Antimicrobial stewardshipCritically ill patientsDe-escalationEmpirical therapyMultidrug-Resistant bacteriaSepsis

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Intensive Care Medicine Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. cruzsoriano@gmail.com.
  • Intensive Care Medicine Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Clinical Microbiology and Infectious Diseases, Hospital Clínico Universitario San Carlos, Madrid, Spain.

ORCID-Profile: María Cruz Soriano-Cuesta, Marina López-Olivencia, Francisco Javier Candel, Susana García-Plaza

Zitieren

APA

Soriano-Cuesta, M. C., López-Olivencia, M., Candel, F. J., & García-Plaza, S. (2025). Therapeutic approach in the critically ill patient with suspected multidrug resistance. Revista Española de Quimioterapia, 38(S1), 63-69. https://doi.org/10.37201/req/s01.10.2025

Vancouver

Soriano-Cuesta MC, López-Olivencia M, Candel FJ, García-Plaza S. Therapeutic approach in the critically ill patient with suspected multidrug resistance. Revista Española de Quimioterapia. 2025;38(S1):63-69. doi:10.37201/req/s01.10.2025

BibTeX
@article{SorianoCuesta2025,
  author = {Soriano-Cuesta, María Cruz and López-Olivencia, Marina and Candel, Francisco Javier and García-Plaza, Susana},
  title = {Therapeutic approach in the critically ill patient with suspected multidrug resistance},
  journal = {Revista Española de Quimioterapia},
  year = {2025},
  volume = {38},
  number = {S1},
  pages = {63--69},
  doi = {10.37201/req/s01.10.2025}
}
Kostenlos starten →